Hybrid polypeptides with selectable properties

The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-rel...

Full description

Saved in:
Bibliographic Details
Main Authors SOUZA LAWRENCE J. D, SOARES CHRISTOPHER J, LEVY ODILE ESTHER, LEWIS DIANA Y, GHOSH SOUMITRA S, JODKA CAROLYN M, PARKES DAVID G, HANLEY MICHAEL R, MACK CHRISTINE M
Format Patent
LanguageChinese
English
Published 07.09.2011
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.
Bibliography:Application Number: CN201110061194